HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tribulosin protects rat hearts from ischemia/reperfusion injury.

AbstractAIM:
To investigate the protective effect of tribulosin, a monomer of the gross saponins from Tribulus terrestris, against cardiac ischemia/reperfusion injury and the underlying mechanism in rats.
METHODS:
Isolated rat hearts were subjected to 30 min of ischemia followed by 120 min of reperfusion using Langendorff's technique. The hearts were assigned to seven groups: control, ischemia/reperfusion (I/R), treatment with gross saponins from Tribulus terrestris (GSTT) 100 mg/L, treatment with tribulosin (100, 10, and 1 nmol/L) and treatment with a PKC inhibitor (chelerythrine) (1 micromol/L). Infarct size was assessed by triphenyltetrazolium chloride staining. Malondialdehyde (MDA), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) contents as well as superoxide dismutase (SOD) and creatine kinase (CK) activities were determined after the treatment. Histopathological changes in the myocardium were observed using hematoxylin-eosin (H&E) staining. Apoptosis was detected with terminal deoxynucleotidyl transferase nick-end labeling (TUNEL) assay. Bcl-2, Bax, caspase-3, and PKCepsilon protein expression were examined using Western blotting.
RESULTS:
Tribulosin treatment significantly reduced MDA, AST, CK and LDH contents, and increased the activity of SOD. The infarct size of I/R group was 40.21% of the total area. GSTT and various concentrations of tribulosin treatment decreased the infarct size to 24.33%, 20.24%, 23.19%, and 30.32% (P<0.01). Tribulosin treatment reduced the myocardial apoptosis rate in a concentration-dependent manner. Bcl-2 and PKCepsilon protein expression was increased after tribulosin preconditioning, whereas Bax and caspase-3 expression was decreased. In the chelerythrine group, Bcl-2 and PKCepsilon expression was decreased, whereas Bax and caspase-3 expression was increased.
CONCLUSION:
Tribulosin protects myocardium against ischemia/reperfusion injury through PKCepsilon activation.
AuthorsShuang Zhang, Hong Li, Shi-jie Yang
JournalActa pharmacologica Sinica (Acta Pharmacol Sin) Vol. 31 Issue 6 Pg. 671-8 (Jun 2010) ISSN: 1745-7254 [Electronic] United States
PMID20453871 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Bax protein, rat
  • Cardiotonic Agents
  • Proto-Oncogene Proteins c-bcl-2
  • Sitosterols
  • bcl-2-Associated X Protein
  • tribulosin
  • Protein Kinase C-epsilon
  • Caspase 3
Topics
  • Animals
  • Apoptosis (drug effects)
  • Cardiotonic Agents (therapeutic use)
  • Caspase 3 (metabolism)
  • Enzyme Activation
  • Female
  • In Vitro Techniques
  • Male
  • Myocardial Ischemia (complications, pathology)
  • Myocardial Reperfusion Injury (prevention & control)
  • Myocardium (chemistry, metabolism, pathology)
  • Phytotherapy
  • Protein Kinase C-epsilon (metabolism)
  • Proto-Oncogene Proteins c-bcl-2 (metabolism)
  • Rats
  • Rats, Wistar
  • Sitosterols (therapeutic use)
  • Tribulus
  • bcl-2-Associated X Protein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: